重组人粒细胞巨噬细胞集落刺激因子加束照射方案替代自体骨髓移植。 - Suppr | 超能文献

Recombinant human granulocyte-macrophage colony-stimulating factor plus the beam regimen instead of autologous bone marrow transplantation.

作者信息

Fouillard L, Gorin N C, Laporte J P, Douay L, Isnard F, Najman A

出版信息

Lancet. 1989 Jun 24;1(8652):1460. doi: 10.1016/s0140-6736(89)90176-1.

DOI:10.1016/s0140-6736(89)90176-1

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Recombinant human granulocyte-macrophage colony-stimulating factor plus the beam regimen instead of autologous bone marrow transplantation.重组人粒细胞巨噬细胞集落刺激因子加束照射方案替代自体骨髓移植。

Lancet. 1989 Jun 24;1(8652):1460. doi: 10.1016/s0140-6736(89)90176-1.

2

BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy.BEAC方案还是BEAM方案用于非霍奇金淋巴瘤患者的大剂量治疗？一项关于毒性和疗效的单中心分析

Leuk Lymphoma. 2003 Jul;44(7):1151-8. doi: 10.1080/1042819031000083028.

3

GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen.在BEAM方案后使用粒细胞巨噬细胞集落刺激因子而非自体骨髓移植。

Lancet. 1991 Sep 7;338(8767):601-2. doi: 10.1016/0140-6736(91)90609-s.

4

[Autologous transplant with BEAM protocol in lymphoma].[淋巴瘤的BEAM方案自体移植]

Sangre (Barc). 1997 Apr;42 Suppl 1:46-9.

5

Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.恶性淋巴瘤自体骨髓移植后，联合及序贯给予重组人粒细胞集落刺激因子和重组人白细胞介素-3以加速造血恢复。

J Clin Oncol. 1996 Nov;14(11):3018-25. doi: 10.1200/JCO.1996.14.11.3018.

6

Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery?大剂量化疗联合自体干细胞移植治疗淋巴系统恶性肿瘤后单剂量聚乙二醇化非格司亭与每日使用非格司亭的比较：血小板恢复延迟？

Blood Transfus. 2012 Oct;10(4):561-2. doi: 10.2450/2012.0148-11. Epub 2012 Feb 22.

7

BEAM protocol and autologous bone marrow transplantation in first chemosensitive relapse of non-Hodgkin's lymphomas.

Eur J Cancer. 1990;26(7):858. doi: 10.1016/0277-5379(90)90180-2.

8

Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma.非霍奇金淋巴瘤患者外周血祖细胞移植后使用粒细胞集落刺激因子

J Clin Oncol. 1995 Apr;13(4):935-41. doi: 10.1200/JCO.1995.13.4.935.

9

Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.卡莫司汀、依托泊苷、阿糖胞苷和美法仑（BEAM）-抗人淋巴细胞球蛋白异基因干细胞移植治疗侵袭性非霍奇金淋巴瘤：英国血液与骨髓移植学会的疗效分析

Biol Blood Marrow Transplant. 2015 Mar;21(3):483-8. doi: 10.1016/j.bbmt.2014.11.673. Epub 2014 Dec 6.

10

A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant.对33例非霍奇金淋巴瘤患者进行长期随访，这些患者仅接受了BEAM大剂量强化方案并辅以细胞因子支持，未进行移植。

Leukemia. 2004 Oct;18(10):1717-21. doi: 10.1038/sj.leu.2403427.

引用本文的文献

1

Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.重组粒细胞-巨噬细胞集落刺激因子（rGM-CSF）：其药理特性及在骨髓抑制管理中的潜在作用综述

Drugs. 1992 Apr;43(4):516-560. doi: 10.2165/00003495-199243040-00008.

2

Haematology.血液学

Postgrad Med J. 1990 Aug;66(778):595-611. doi: 10.1136/pgmj.66.778.595.

3

Granulocyte-macrophage colony-stimulating factor (GM-CSF): what role in bone marrow transplantation?

Infection. 1992;20 Suppl 2:S95-9. doi: 10.1007/BF01705025.